Artificial surfactant therapy for hyaline membrane disease.
D000818:Animals; D005333:Fetus; D006801:Humans; D006819:Hyaline Membrane Disease / Q000188:drug therapy*; D007223:Infant; D007231:Infant, Newborn; D008168:Lung / Q000187:drug effects / Q000196:embryology; D010715:Phosphatidylglycerols / Q000494:pharmacology / Q000627:therapeutic use*; D011663:Pulmonary Surfactants / Q000494:pharmacology / Q000627:therapeutic use*; D011817:Rabbits
D010715:Phosphatidylglycerols; D011663:Pulmonary Surfactants